IN B004
Alternative Names: IN-B004Latest Information Update: 28 May 2024
At a glance
- Originator HK inno.N
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Autoimmune disorders
Highest Development Phases
- No development reported Autoimmune disorders
Most Recent Events
- 28 May 2024 No recent reports of development identified for preclinical development in Autoimmune-disorders in South Korea
- 29 Jul 2020 IN B004 is available for licensing as of 29 Jul 2020. IN B003 is available for licensing as of 29 Jul 2020. http://www.inno-n.com/eng/business/out_licensing.asp
- 18 Jun 2020 CJ HealthCare is now called HK inno.N